IL96260A - תכשירי רוקחות המכילים נגזרות ואנלוגים של פירימידון לטיפול בקצרת במחלות עור ודלקות - Google Patents
תכשירי רוקחות המכילים נגזרות ואנלוגים של פירימידון לטיפול בקצרת במחלות עור ודלקותInfo
- Publication number
- IL96260A IL96260A IL9626090A IL9626090A IL96260A IL 96260 A IL96260 A IL 96260A IL 9626090 A IL9626090 A IL 9626090A IL 9626090 A IL9626090 A IL 9626090A IL 96260 A IL96260 A IL 96260A
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- asthma
- pharmaceutical composition
- bicyclo
- hept
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1989/005221 WO1991007177A1 (en) | 1989-11-13 | 1989-11-13 | Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
IL96260A0 IL96260A0 (en) | 1991-08-16 |
IL96260A true IL96260A (he) | 1995-11-27 |
Family
ID=22215372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9626090A IL96260A (he) | 1989-11-13 | 1990-11-06 | תכשירי רוקחות המכילים נגזרות ואנלוגים של פירימידון לטיפול בקצרת במחלות עור ודלקות |
Country Status (17)
Country | Link |
---|---|
US (1) | US5342842A (he) |
EP (1) | EP0428313B1 (he) |
JP (2) | JPH0662412B2 (he) |
KR (1) | KR930001832B1 (he) |
AT (1) | ATE101040T1 (he) |
AU (1) | AU627631B2 (he) |
CA (1) | CA2029704C (he) |
DE (1) | DE69006452T2 (he) |
DK (1) | DK0428313T3 (he) |
HU (1) | HU212311B (he) |
IE (1) | IE63472B1 (he) |
IL (1) | IL96260A (he) |
MY (1) | MY111474A (he) |
NZ (1) | NZ236038A (he) |
PT (1) | PT95854B (he) |
WO (2) | WO1991007177A1 (he) |
ZA (1) | ZA909043B (he) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PH31245A (en) * | 1991-10-30 | 1998-06-18 | Janssen Pharmaceutica Nv | 1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives. |
BR9307570A (pt) * | 1992-12-02 | 1999-05-25 | Pfizer | Diéteres de catecol como inibidores seletivos de pdeiv |
US5814651A (en) * | 1992-12-02 | 1998-09-29 | Pfizer Inc. | Catechol diethers as selective PDEIV inhibitors |
US5482944A (en) * | 1993-07-13 | 1996-01-09 | Pfizer Inc. | Pyrimidones and imidazolinones for treatment of shock |
US5502072A (en) * | 1993-11-26 | 1996-03-26 | Pfizer Inc. | Substituted oxindoles |
ES2139754T3 (es) * | 1993-11-26 | 2000-02-16 | Pfizer | 3-fenil-2-isoxazolinas como agentes antiinflamatorios. |
AU1326795A (en) * | 1994-03-09 | 1995-09-25 | Pfizer Inc. | Isoxazoline compounds as 5-lipoxygenase inhibitors |
WO1995024398A1 (en) * | 1994-03-09 | 1995-09-14 | Pfizer Inc. | Isoxazoline compounds as inhibitors of tnf release |
US5563143A (en) * | 1994-09-21 | 1996-10-08 | Pfizer Inc. | Catechol diether compounds as inhibitors of TNF release |
EP0934307B1 (en) | 1996-06-19 | 2011-04-27 | Aventis Pharma Limited | Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
WO1998008828A1 (fr) * | 1996-08-27 | 1998-03-05 | Nikken Chemicals Co., Ltd. | Derives du 2-phenylmorpholin-5-one et composition pharmaceutique les comprenant |
CA2402384A1 (en) * | 2000-03-16 | 2001-09-20 | Inflazyme Pharmaceuticals Ltd. | Benzylated pde4 inhibitors |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2401446A1 (de) * | 1973-01-16 | 1974-07-25 | Voorhees | Pharmazeutische zubereitungen zur linderung von hautproliferationserkrankungen |
SU888821A3 (ru) * | 1976-12-03 | 1981-12-07 | Шеринг Аг (Инофирма) | Способ получени 5-(замещенный фенил)-оксазолидинонов или их серусодержащих аналогов |
DE3315797A1 (de) * | 1983-04-30 | 1984-10-31 | Beiersdorf Ag, 2000 Hamburg | Substituierte phenyl-2-(1h)-pyrimidinone, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen |
GB8416140D0 (en) * | 1984-06-25 | 1984-08-01 | Fujisawa Pharmaceutical Co | Pyrimidinone derivatives |
WO1987006576A1 (en) * | 1986-04-29 | 1987-11-05 | Pfizer Inc. | Calcium independent camp phosphodiesterase inhibitor antidepressant |
-
1989
- 1989-11-13 WO PCT/US1989/005221 patent/WO1991007177A1/en unknown
-
1990
- 1990-04-20 HU HU9201575A patent/HU212311B/hu not_active IP Right Cessation
- 1990-04-20 WO PCT/US1990/002162 patent/WO1991007178A1/en unknown
- 1990-04-20 US US07/855,046 patent/US5342842A/en not_active Expired - Fee Related
- 1990-11-06 DK DK90312117.6T patent/DK0428313T3/da active
- 1990-11-06 IL IL9626090A patent/IL96260A/he active IP Right Grant
- 1990-11-06 DE DE90312117T patent/DE69006452T2/de not_active Expired - Fee Related
- 1990-11-06 EP EP90312117A patent/EP0428313B1/en not_active Expired - Lifetime
- 1990-11-06 AT AT90312117T patent/ATE101040T1/de not_active IP Right Cessation
- 1990-11-09 MY MYPI90001979A patent/MY111474A/en unknown
- 1990-11-09 CA CA002029704A patent/CA2029704C/en not_active Expired - Fee Related
- 1990-11-12 AU AU66536/90A patent/AU627631B2/en not_active Ceased
- 1990-11-12 KR KR1019900018241A patent/KR930001832B1/ko not_active IP Right Cessation
- 1990-11-12 IE IE405890A patent/IE63472B1/en not_active IP Right Cessation
- 1990-11-12 PT PT95854A patent/PT95854B/pt not_active IP Right Cessation
- 1990-11-12 NZ NZ236038A patent/NZ236038A/en unknown
- 1990-11-12 ZA ZA909043A patent/ZA909043B/xx unknown
- 1990-11-13 JP JP2306973A patent/JPH0662412B2/ja not_active Expired - Fee Related
-
1994
- 1994-02-03 JP JP6011680A patent/JP2514163B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
IL96260A0 (en) | 1991-08-16 |
EP0428313A3 (en) | 1991-11-06 |
DE69006452D1 (de) | 1994-03-17 |
DE69006452T2 (de) | 1994-05-11 |
JPH0662412B2 (ja) | 1994-08-17 |
AU6653690A (en) | 1991-08-01 |
DK0428313T3 (da) | 1994-03-07 |
NZ236038A (en) | 1997-03-24 |
KR910009259A (ko) | 1991-06-28 |
JPH0748255A (ja) | 1995-02-21 |
HUT70052A (en) | 1995-09-28 |
HU212311B (en) | 1996-05-28 |
CA2029704C (en) | 1995-02-07 |
JP2514163B2 (ja) | 1996-07-10 |
US5342842A (en) | 1994-08-30 |
HU9201575D0 (en) | 1993-04-28 |
WO1991007177A1 (en) | 1991-05-30 |
EP0428313A2 (en) | 1991-05-22 |
JPH03209322A (ja) | 1991-09-12 |
IE904058A1 (en) | 1991-05-22 |
PT95854A (pt) | 1991-09-13 |
EP0428313B1 (en) | 1994-02-02 |
ATE101040T1 (de) | 1994-02-15 |
MY111474A (en) | 2000-06-30 |
ZA909043B (en) | 1992-06-24 |
CA2029704A1 (en) | 1991-05-14 |
PT95854B (pt) | 1997-11-28 |
AU627631B2 (en) | 1992-08-27 |
KR930001832B1 (ko) | 1993-03-15 |
WO1991007178A1 (en) | 1991-05-30 |
IE63472B1 (en) | 1995-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0428302B1 (en) | Enzymatic resolution of endo-bicycle(2.2.1)-heptan-2-ol and derived pharmaceutical agents | |
US6869956B2 (en) | Methods of treating inflammatory and immune diseases using inhibitors of IκB kinase (IKK) | |
US5342842A (en) | Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders | |
IE54423B1 (en) | Combination of 2-substituted penems with dipeptidase inhibitors | |
AU2002247059B2 (en) | Method of treating inflammatory and immune diseases using inhibitors of IkappaB kinase (IKK) | |
AU2002247059A1 (en) | Method of treating inflammatory and immune diseases using inhibitors of IkappaB kinase (IKK) | |
JP3808921B2 (ja) | 細胞接着阻害剤 | |
JPS61246183A (ja) | 置換1,8‐ナフチリジノン類、それらの製造方法およびそれらを含む医薬組成物 | |
US5270206A (en) | Enzymatic resolution of endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents | |
US5461056A (en) | Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders | |
CA2048959C (en) | 3-(1,2-benzisoxazol-3-yl)-4-pyridinamines and derivatives | |
JPH06505698A (ja) | 新規化合物 | |
US4880793A (en) | Combination of thienamycin-type antibiotics with dipeptidase inhibitors | |
JPH0678230B2 (ja) | 好中球によるエラスターゼの遊離の阻害剤としてのテニダップ | |
JPH07196509A (ja) | イソキノリン誘導体を含有する医薬組成物 | |
US5395935A (en) | Endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents | |
JPS632964A (ja) | 腎臓ジペプチダ−ゼ阻害剤としてのビス(シクロプロパンカルボキサミド)アルカジエンジオン酸 | |
JPH09301868A (ja) | 抗白内障剤 | |
JPH04503509A (ja) | ピリミド―ピリミジンリポキシゲナーゼ阻害化合物 | |
EP0497609A1 (en) | Pyrimido-benzothiazine derivatives for the treatment of inflammation, allergy and cardiovascular disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed |